Scientists created a definitive E3 ligase atlas, resolving inconsistencies and enabling better disease research and drug ...

In a field driven by packaging, promises, and relentless product launches, Dr. Ronit Segev prefers to focus on what most people never see: cellular behavior, pigment pathways, and inflammatory ...

What does the future hold for sign language and artificial intelligence? No one knows for sure, but at the inaugural SLxAI ...

Learn from this 7 monogamous animals about long-term bonding, loyalty, and commitment through science and behavior in nature.

When your brain goes offline during a stressful time, it might be emotional flooding.

Initial results from a high-stakes trial indicate the biotech may have finally found a niche in lymphoma care for a ...

In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...

Mesoblast offers asymmetric risk-reward with Ryoncil's rapid pediatric SR-aGvHD launch and multiple late-stage pipeline catalysts. Learn why MESO stock is a hold.

Cancer metabolism has re-emerged as a central hallmark of tumor initiation, progression, and therapeutic resistance. Advances in high-throughput ...

Nextstar Energy Inc. was registered this past week by Hunseong Lee, the company’s CEO, to lobby. A battery manufacturer whose ...

Cell-based assay innovation is reshaping how we discover, validate, and de-risk therapeutic candidates across disease areas. This Research Topic invites ...

Fish living downstream of wastewater treatment plants are accumulating antidepressants, opioids and other drugs of abuse in ...